Submitted by Anonymous (not verified) on 18 May 2026 - 11:00
Human medicines European public assessment report (EPAR): Sapropterin Dipharma, sapropterin, Date of authorisation: 16/02/2022, Revision: 8, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Sapropterin Dipharma, sapropterin, Date of authorisation: 16/02/2022, Revision: 8, Status: Authorised